Company intelligence / Profile preview
CellGENTherapies
- Ownership
- Private
- Development stage
- Other
Overview
CellGEN Therapies is an emerging biotechnology company focused on the development of next-generation cell and gene therapies. The company leverages a proprietary platform designed to enhance the precision and efficacy of engineered cell treatments for oncology and autoimmune indications. By optimizing the delivery and expression of therapeutic genes, CellGEN aims to overcome current limitations in durability and safety associated with first-generation CAR-T and gene-modified therapies. The company is currently advancing its internal pipeline through the pre-clinical stage while exploring strategic collaborations to expand its technological reach.
- Therapeutic areas
- OncologyImmunology
- Modalities
- Cell therapyGene therapyCAR-T cell therapy
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on CellGENTherapies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CellGENTherapies.